Filing date Form Description Issuer View
8-K

Report of unscheduled material events or corporate event

Intellia Therapeutics, Inc. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Intellia Therapeutics, Inc. EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
8-K

Report of unscheduled material events or corporate event

Intellia Therapeutics, Inc. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Intellia Therapeutics, Inc. View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Intellia Therapeutics, Inc. View HTML
3

Initial filing by director officer or owner of more than ten percent.

Intellia Therapeutics, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

Intellia Therapeutics, Inc. View HTML
4/A

Amendment to a previously filed 4

Intellia Therapeutics, Inc. View HTML
3

Initial filing by director officer or owner of more than ten percent.

Intellia Therapeutics, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

Intellia Therapeutics, Inc. View HTML

Data provided by Kaleidoscope.